Ho Yeong Lim
Ho Yeong Lim publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Hepatology, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies and Gastric Cancer Management and Outcomes.
- World rank
- #108,787 of 7,710,434 ranked researchers
- Rank in South Korea
- #522 of 162,609
- Works
- 590
- Citations
- 41k
- Citations per work
- 69.0
What does Ho Yeong Lim research?
Ho Yeong Lim's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences39066.1%
- Medicine39066.1%
- Everything else12320.9%
- Life Sciences7713.0%
- 1Oncology24% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Hepatology13% of their works
- 4Surgery11% of their works
- 5Molecular Biology7% of their works
- 6Cancer Research6% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
Which keywords describe Ho Yeong Lim's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Hepatocellular Carcinoma, Liver Cancer, Tumor Microenvironment, Cetuximab, KRAS Mutations and Targeted Therapy.
- EGFR Mutations
- Surgical Complications
- Mutational Signatures
- PD-1 and PD-L1
- Cholangiocarcinoma
- Gastric Cancer
- Targeted Therapy
- Cetuximab
- Liver Cancer
- Clinical Practice Guidelines
- Chemotherapy
- Hepatocellular Carcinoma
- Tumor Microenvironment
- KRAS Mutations
- Endoscopic Resection
- Biliary Tract Cancer
- Immune Checkpoint Blockade
- Cancer Genomics
- Pancreatic Cancer
- ALK Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy2683 topics
- Clinical Practice Guidelines2652 topics
- Hepatocellular Carcinoma1721 topic
- Liver Cancer1721 topic
- Tumor Microenvironment1272 topics
- Cetuximab1201 topic
- KRAS Mutations1201 topic
- Targeted Therapy1072 topics
- Endoscopic Resection931 topic
- Gastric Cancer931 topic
- Biliary Tract Cancer901 topic
- Cholangiocarcinoma901 topic
- Immune Checkpoint Blockade721 topic
- PD-1 and PD-L1721 topic
- Cancer Genomics561 topic
- Mutational Signatures561 topic
- Pancreatic Cancer551 topic
- Surgical Complications551 topic
- ALK Inhibitors511 topic
- EGFR Mutations511 topic
Where does Ho Yeong Lim work?
Ho Yeong Lim's main affiliation in the publication record is Samsung Medical Center, South Korea.
How many publications and citations does Ho Yeong Lim have?
OpenAlex counts 590 works and 40,726 citations for Ho Yeong Lim, an h-index of 79, ranking #108,787 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ho Yeong Lim
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ho Yeong Lim. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.